News & Updates
What's moving in medical-grade honey.
Recalls, regulation, peer-reviewed research and industry developments — with concise expert commentary. New posts as the category evolves.
Commentary · 30 May 2026 · 6 min read
Biofilms — the hidden pandemic nobody is talking about
Biofilms cost the global economy an estimated $4 trillion a year and sit inside ~78% of chronic wounds, yet most people have never heard of them. Why MGO-rich Manuka honey remains one of the few tools with multi-mechanism antibiofilm activity.
Recall · 29 May 2026 · 6 min read
What the historic Medihoney recall tells us about medical-grade honey QA
Voluntary recalls of honey-based dressings are rare but instructive. We unpack what tends to drive them — bioburden, packaging integrity, MGO drift — and what a robust QA file looks like.
Regulation · 21 May 2026 · 5 min read
MHRA medical-device reclassification — why honey dressings are worth watching
Post-EU-MDR divergence means UK Class IIb wound-care products face a different evidentiary bar. We summarise the current MHRA position and where honey-based dressings sit today.
Research · 15 May 2026 · 6 min read
Biofilm + MGO — the 2026 evidence roundup
A short read across the most cited 2025–2026 papers on methylglyoxal activity against staphylococcal and pseudomonal biofilms — and what is still missing from the picture.
Subscribe via RSS feed.